| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Tofogliflozin (hydrate) |
|---|
| Description | A potent inhibitor of SGLT2 (Kis = 2.9, 14.9, and 6.4 nM for human, rat, and mouse SGLT2, respectively); selective for SGLT2 (IC50 = 2.9 nM) over other SGLTs (IC50s = >1,500 nM for SGLT1 and 3-6); reduces plasma glucose concentration and increases renal glucose clearance in Zucker diabetic fatty rats in a dose-dependent manner when administered at doses ranging from 3-10 mg/kg; reduces hyperglycemia in non-fasted db/db mice and decreases postprandial hyperglycemia in GK rats, a non-obese model of type 2 diabetes with glucose intolerance, |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 903565-83-3 Deberza CSG-452 SGLT-1 2 CSG452 SGLT3 SGLT4 SGLT5 SGLT6 |
|---|
| Gene, Accession, CAS # | CAS: 1201913-82-7 |
|---|
| Catalog # | 23509-10 |
|---|
| Price | |
|---|
| Order / More Info | Tofogliflozin (hydrate) from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|